8-K
NEWNovanta Announces Third Quarter 2026 Financial Results and Raises Full-Year Guidance
8-K/A
Audited 2025 Statements Report $136.1 Million Revenue, $11.5 Million Net Income, and $27.1 Million Operating Cash Flow
8-K
Novanta Reports Second Quarter 2026 Financial Results and Announces Acquisition of Riverpoint Medical
8-K
Novanta Completes Acquisition of Riverpoint Medical
8-K
Novanta Inc. Announces $300 Million Private Placement of Common Shares
8-K
Novanta Inc. Announces Acquisition of Riverpoint Medical
